| Presenter |
Presentation |
Joyce Graff, E.D., Cancer Research Fund-VHL Alliance |
Teamwork for Health |
Susanne Schlisio, Ph.D, Dana Farber Cancer Research Center. Her research is funded in part by VHLFA |
Progress in Research:
an update on the state of research, some of the leading candidates for drugs to help prevent, stall, or shrink tumors. Dr. Schlisio will help us understand, for example, how flaws in any one of five different genes can produce a pheo. |
Donald Bellgrau, Ph.D., Professor of Immunology and Medicine, University of Colorado at Denver. |
Targeting Cancer-Specific Mutations with Immunotherapy |
Dr. Richard H. Cohan, Department of Radiology, University of Michigan |
Imaging and Contrast:
Dr. Cohan will speak about the use of different oral contrast agents for CT scans, including the use of water and milk. He will talk briefly about advances in CT for detecting renal tumors. He will also review issues related to a newly diagnosed entity called nephrogenic systemic fibrosis, which may be linked to intravenous administration of gadolinium in some patients referred for MRI examinations, and then answer any questions regarding the performance of imaging procedures. |
Amy Budd, Artist in Residence at the Perishable Theater Arts Program, Providence, RI. |
Feeling Powerful and Beautiful Again:
interactive presentation. Wear comfortable clothes and be prepared to MOVE! Amy devised creative movement methods to help her in her recovery from brain surgery. |
Dr. Arthur Tischler, Tufts New England Medical Center, Senior
Pathologist with a specialization in neuro-endocrine and adrenal disease.
Dr. Ron Lechan, Tufts New England Medical Center, Chief of the Division of Endocrinology |
Diagnosis and Treatment of Pheochromocytomas |
Four patients from the Boston area, with pheos of various genetic origins |
The Rocky Road to Diagnosis:
A panel of patients share their own stories of diagnosis of pheos |
Scott Plotkin, M.D., Mass. General Hospital |
Clinical Trials for Kidney tumors |
Othon Iliopoulos, M.D., Mass. General Hospital |
Progress toward Biomarkers for Kidney Cancer |
Nahum Goldberg, M.D., Interventional Radiology, Beth Israel Hospital |
Radio Frequency Ablation and the kidney:
Dr. Goldberg shares with us his newest techniques for optimizing the use of radio frequence ablation with kidney tumors. |
Steven K. Libutti, M.D., National Institutes of Health, reporting on his focused study on VHL in the pancreas at NIH |
Understanding Pancreatic Lesions in VHL:
Dr. Libutti discusses the challenges of diagnosis and his current recommendations for treatment and management. |
